NEW YORK, Feb 21 – Variagenics said Wednesday it sold its NuCleave genotyping and haplotyping system to the Amsterdam Genomics Center at the University of Amsterdam.

The Amsterdam Genomics Center is Variagenics’ second announced customer for NuCleave. Variagenics launched NuCleave in the fourth quarter of 2000 and placed its first system at Covance, which is using the system for genetic variance determination in clinical trials.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.